GIGA-2050 is a new class of drug designed to provide passive immunity to COVID-19 patients or those at high risk.... Sep 16
Novavax aims for 2 billion COVID-19 vaccine doses with expanded Serum Institute, India deal ... Sep 16
Lesser drug recalls with DSCSA supply chain... Sep 16
End-to-end solution and components offer flexibility to testing facilities, meeting high-volume demand and significantly boosting global testing capacity ... Sep 16
-Advertisements-